Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Christine Getter"'
Autor:
Cláudia Yang Santos, Christine Getter, John Stoukides, Brian Ott, Stephen Salloway, Michaela Petrini, Miguel Garcia, William Rehehan, Jason Machan, Paula Grammas
BACKGROUND The precise mechanisms whereby cardiovascular risk factors increase the risk of Alzheimer’s disease (AD) have not been delineated. We reported that microvessels isolated from AD brains overexpress a diverse array of neurotoxic and inflam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20f6ab12d35f67919c6809fe4a6e0795
https://doi.org/10.2196/preprints.14905
https://doi.org/10.2196/preprints.14905
Autor:
Paula Grammas, Brian R. Ott, Christine Getter, John Stoukides, Cláudia Y. Santos, William E. Renehan, Stephen Salloway
Publikováno v:
Alzheimer's & Dementia. 15:P1278-P1279
Publikováno v:
Alzheimer's & Dementia. 12:454-458
Introduction Three 18 F-labeled radiopharmaceuticals have been Food and Drug Administration-approved for the identification of cortical amyloidosis in clinical settings. Although there has been strong debate among professionals as to the ethical and
Autor:
Yen Ying Lim, Rachel Schindler, Paul Maruff, Christine Getter, Peter J. Snyder, Richard B. Noto, Cláudia Y. Santos, Don C. Yoo, Brian R. Ott, Stephen Salloway
Publikováno v:
Alzheimer's & Dementia. 13
Autor:
Michelle Site, Cláudia Y. Santos, Christine Getter, YenYing Lim, Paul Maruff, Peter J. Snyder
Publikováno v:
Alzheimer's & Dementia. 11
Autor:
Yen Ying Lim, Michelle Site, Christine Getter, Rachel Schindler, Brian R. Ott, Stephen Salloway, Paul Maruff, Peter J. Snyder
Publikováno v:
Alzheimer's & Dementia. 10
Autor:
Lori A. Daiello, Stephen Salloway, Catherine M. Gordon, Brian R. Ott, Yen Ying Lim, Rachel Schindler, Paul Maruff, Peter J. Snyder, Christine Getter
Publikováno v:
Alzheimer'sdementia : the journal of the Alzheimer's Association. 10(2)
Background Abnormal β-amyloid (Aβ) is associated with deleterious changes in central acetylcholinergic tone in the very early stages of Alzheimer's disease (AD), which may be unmasked by a cholinergic antagonist. We aimed to establish an optimal "m